BNP Paribas Financial Markets’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-17,815
| Closed | -$522K | – | 4373 |
|
|
2017
Q3 | $522K | Buy |
17,815
+5,590
| +46% | +$157K | ﹤0.01% | 1966 |
|
|
2017
Q2 | $321K | Buy |
12,225
+3,636
| +42% | +$89.4K | ﹤0.01% | 2157 |
|
|
2017
Q1 | $201K | Sell |
8,589
-1,343
| -14% | -$33.1K | ﹤0.01% | 2211 |
|
|
2016
Q4 | $250K | Buy |
9,932
+5,024
| +102% | +$127K | ﹤0.01% | 2075 |
|
|
2016
Q3 | $138K | Sell |
4,908
-5,395
| -52% | -$138K | ﹤0.01% | 1944 |
|
|
2016
Q2 | $254K | Buy |
10,303
+5,060
| +97% | +$126K | ﹤0.01% | 1809 |
|
|
2016
Q1 | $116K | Sell |
5,243
-2,067
| -28% | -$55K | ﹤0.01% | 1743 |
|
|
2015
Q4 | $256K | Buy |
7,310
+521
| +8% | +$16.3K | ﹤0.01% | 1764 |
|
|
2015
Q3 | $193K | Buy |
6,789
+4,019
| +145% | +$135K | ﹤0.01% | 1978 |
|
|
2015
Q2 | $92.2K | Buy |
2,770
+2,056
| +288% | +$63.1K | ﹤0.01% | 2127 |
|
|
2015
Q1 | $20.1K | Buy |
+714
| New | +$17.7K | ﹤0.01% | 2362 |
|
|
2014
Q4 | – | Sell |
-1,765
| Closed | -$43.1K | – | 3749 |
|
|
2014
Q3 | $43.1K | Buy |
1,765
+1,709
| +3,052% | +$45.3K | ﹤0.01% | 2690 |
|
|
2014
Q2 | $1.6K | Buy |
+56
| New | +$1.56K | ﹤0.01% | 3224 |
|
|
2014
Q1 | – | Sell |
-385
| Closed | -$8.28K | – | 4050 |
|
|
2013
Q4 | $8.28K | Buy |
+385
| New | +$7K | ﹤0.01% | 2764 |
|
|
2013
Q3 | – | Sell |
-10,038
| Closed | -$139K | – | 2800 |
|
|
2013
Q2 | $139K | Buy |
+10,038
| New | +$142K | ﹤0.01% | 2464 |
|
BNP Paribas Financial Markets's PMC Position: Q4 2017 in Review
BNP Paribas Financial Markets sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 17,815 shares — an estimated $522K sold.
BNP Paribas Financial Markets first reported a position in PMC in Q2 2013 and held it in 15 quarters. The position peaked at $522K in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- BNP Paribas Financial Markets reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- BNP Paribas Financial Markets sold 17,815 PharMerica Corporation shares in Q4 2017, an estimated $522K.
- BNP Paribas Financial Markets first reported a position in PharMerica Corporation in Q2 2013 and held it in 15 quarters.
- BNP Paribas Financial Markets's PharMerica Corporation position peaked at $522K in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2017, filed 1 Feb 2018.